Castellan Group Novo Nordisk A S Transaction History

Castellan Group

$236 Million
Q3 2024

A detailed history of Castellan Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Castellan Group holds 29,276 shares of NVO stock, worth $2.37 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares

29,276

Previous 42,471 31.07%

Holding current value

$2.37 Million

Previous $6.06 Million 42.51%

% of portfolio

1.48%

Previous 3.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 25, 2024	SELL	$119.07 - $145.42 $1.57 Million - $1.92 Million	-13,195 Reduced 31.07%	29,276 $3.49 Million
Q2 2024 Aug 09, 2024	BUY	$122.71 - $146.91 $265,299 - $317,619	2,162 Added 5.36%	42,471 $6.06 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $57,794 - $76,930	-566 Reduced 1.38%	40,309 $5.18 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $1.68 Million - $3.69 Million	18,501 Added 82.69%	40,875 $3.72 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $528,928 - $585,456	-3,391 Reduced 13.16%	22,374 $3.62 Million
Q1 2023 May 17, 2023	SELL	$132.34 - $159.14 $299,088 - $359,656	-2,260 Reduced 8.06%	25,765 $4.1 Million
Q4 2022 Feb 16, 2023	SELL	$102.55 - $135.33 $31,277 - $41,275	-305 Reduced 1.08%	28,025 $3.79 Million
Q3 2022 Nov 15, 2022	SELL	$95.28 - $116.93 $342,531 - $420,363	-3,595 Reduced 11.26%	28,330 $2.82 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $135,244 - $159,571	1,310 Added 4.28%	31,925 $3.55 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $135,244 - $159,571	-1,310 Reduced 4.1%	30,615 $3.41 Million
Q1 2022 May 23, 2022	BUY	$93.1 - $112.54 $307,695 - $371,944	3,305 Added 11.55%	31,925 $3.55 Million
Q4 2021 Feb 16, 2022	BUY	$95.88 - $117.08 $642,396 - $784,436	6,700 Added 30.57%	28,620 $3.21 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $1.85 Million - $2.34 Million	21,920 New	21,920 $2.11 Million

Others Institutions Holding NVO

# of Institutions

1,918

Shares Held

318M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $183B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castellan Group, based on Form 13F filings with the SEC.

News

Stay updated on Castellan Group with notifications on news.

Account